Delivery Order SPE2DB22D1017-SPE2DB25FH0EJ
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,730.63 to AmerisourceBergen Drug Corp for the supply of Triamterene-HCTZ 37.5-25 mg tablets in quantities of 500 units. This non-set-aside, firm fixed-price delivery order was competitively awarded on August 8, 2025, with an ultimate completion date of August 11, 2025. The medication will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary operations. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Triamterene-HCTZ 37.5-25 mg tablets in a quantity of 500 units, with a ceiling value of $1,267.99. This is a firm fixed-price delivery order with an ultimate completion date of August 8, 2025, and represents a non-competitive set-aside award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery...
- The Defense Logistics Agency awarded a delivery order valued at $2,109.29 to AmerisourceBergen Drug Corp for the supply of Triamterene 50 mg capsules (100 count) on August 12, 2025, with an ultimate completion date of August 13, 2025. This is a firm fixed price, non-set-aside delivery order to be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a delivery order valued at $1,085.19 to AmerisourceBergen Drug Corp for 500 tablets of Triamterene-HCTZ 37.5-25 mg, a generic combination diuretic medication commonly used in the treatment of hypertension. Awarded on July 25, 2025, with an ultimate completion date of July 28, 2025, this firm fixed price delivery order represents a routine pharmaceutical procurement under a non-set-aside competitive award. The contract will be performed at...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,668.35 firm fixed-price delivery order is for the supply of TRIAMTERENE-HCTZ 37.5-25 MG TB 500S, a cardiovascular medication. The contract has an ultimate completion date of December 3, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award, valued at $2,518.18, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract involves the delivery of Triamterene-HCTZ 37.5-25 mg tablets in 500-count packages, with a performance period ending on May 15, 2025. The contract is a firm-fixed price delivery order and is not set-aside. Amerisourcebergen Drug Corp is the prime contractor and holds a larger Indefinite Delivery Contract (IDC) with the...
- The U.S. government's Defense Logistics Agency (DLA) Troop Support Medical awarded a Firm Fixed Price Delivery Order contract, SPE2DX15D3017|SPE2DX24F0MNE, to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,440.34 contract is for the supply of 4565048086 - TRIAMTERENE-HCTZ 37.5-25 MG TB 500S, with a completion date of July 2, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,235.12 firm fixed price contract is for the delivery of Triamterene-HCTZ 37.5-25 mg tablets in 500-count bottles. The award has no set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,454.28, is for the delivery of TRIAMTERENE-HCTZ 37.5-25 MG tablets in quantities of 500 per bottle. The contract is a Firm Fixed Price Delivery Order, with a period of performance through February 12, 2025. This award is not designated as a set-aside contract. AmerisourceBergen maintains a...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract, valued at $1,003.27, is a delivery order with a firm fixed price pricing type. It is for the supply of TRIAMTERENE-HCTZ 37.5-25 MG TB 500S, a generic pharmaceutical product, with a completion date of June 10, 2024. The contract does not have a set-aside designation, indicating open competition....
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB25FH0EJDelivery Order
The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $1,347.67 on August 19, 2025, for the supply of Triamterene-HCTZ 75-50 mg tablets in quantities of 500 units. This competitively awarded, firm fixed-price contract is scheduled for completion by August 20, 2025, with performance to be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. The award carries no set-aside designation, reflecting open competition among qualified pharmaceutical suppliers. This delivery order represents a child contract issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical federal medical procurement vendor for military and veteran healthcare systems. The company's delivery orders under this IDC framework consistently employ firm fixed pricing across a comprehensive range of pharmaceutical products and medical supplies, supporting defense health operations worldwide through the Defense Health Agency and other government healthcare entities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 8/19/25 |